HIGH BASELINE PATIENT’S COMPARED WITH EVALUATOR’S GLOBAL ASSESSMENT IS ASSOCIATED WITH LOWER RETENTION AND REMISSION RATES OF FIRST TNF INHIBITOR IN AXSPA PATIENTS: DATA FROM THE EUROSPA COLLABORATION

Brigitte Michelsen, Lykke Ørnbjerg, Anne Gitte Loft, Joseph Sexton, Adrian Ciurea, Heřman Mann, Kari Eklund, Ayten Yazici, Maria Jose Santos, Johan Askling, Ziga Rotar, Björn Gudbjornsson, Manuel Pombo-suarez, Catalin Codreanu, Irene Van Der Horst-bruinsma, Eirik Kristianslund, Michael Nissen, Karel Pavelka, Nina Trokovic, Nevsun InancElsa Vieira-sousa, Daniela Di Giuseppe, Matija Tomsic, Arni Jon Geirsson, Ruxandra Ionescu, Marleen Van De Sande, Florenzo Iannone, Carlos Sánchez-piedra, Gareth T. Jones, Lise Hyldstrup, Niels Steen Krogh, Merete L. Hetland, Mikkel Østergaard

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article numberFRI0403
JournalAnnals of the Rheumatic Diseases
Volume78
Issue numberSuppl 2
Pages (from-to)887-888
ISSN0003-4967
DOIs
Publication statusPublished - 2019

Cite this